SkinHealth Systems Inc.

SKIN Nasdaq SEC CIK 1818093
Follow SkinHealth Systems Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $69.2M −2.1% vs same quarter last year
Net income −$888K +91.9% vs same quarter last year
EPS, diluted −$0.14 +92% vs same quarter last year
Operating cash flow $11.3M +16.8% vs same quarter last year
Revenue by quarter
$83.5M
$69.6M
$78.2M
$70.7M
$82.4M
$64.9M
$72.1M
$69.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$300.8M−$9.5M
FY24$334.3M−$29.1M
FY23$398M−$100.1M
FY22$365.9M-
FY21$260.1M-
FY20$119.1M−$29.2M
FY19$166.6M−$1.6M
FY18--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%0%50%100%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2565.3%−6.9%−3.2%
FY2454.5%−20.3%−8.7%
FY2339%−32.9%−25.2%
FY2268%−7.1%-
FY2168.6%−15.4%-
FY2056.4%−14.4%−24.5%
FY1963.9%8.1%−1%
FY18---
Free cash flowOperating cash flow minus capital expenditure
−$150M−$100M−$50M$0$50MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$37.2M
FY24$15.4M
FY23$17.9M
FY22−$117.4M
FY21−$39.6M
FY20−$15.9M
FY19−$7M
FY18-
Returned to shareholdersDividends paid and shares bought back
$0$50M$100M$150M$200MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearBuybacks
FY25$0
FY24$0
FY23$30.2M
FY22$160M
FY21$0
FY20$154K
FY19$0
FY18-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • SkinHealth Systems
  • Healthcare median
−100%−75%−50%−25%0%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearSkinHealth SystemsHealthcare median
FY25−3.2%−30.6%
FY24−8.7%−47%
FY23−25.2%−58%
FY22-−80.4%
FY21-−71.8%
FY20−24.5%−62.2%
FY19−1%−46.2%
FY18-−49.6%